Champlain Investment Partners’s Teladoc Health TDOC Stock Holding History

Champlain Investment Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-212,305	Closed	-$32.9M	–	124
2020 Q1	$32.9M	Sell	212,305 -1,049,595	-83%	-$122M	0.3%	102
2019 Q4	$106M	Buy	1,261,900 +114,875	+10%	+$8.74M	0.77%	56
2019 Q3	$77.7M	Buy	1,147,025 +234,110	+26%	+$15.4M	0.64%	71
2019 Q2	$60.6M	Buy	912,915 +89,795	+11%	+$5.23M	0.51%	85
2019 Q1	$45.8M	Buy	823,120 +221,400	+37%	+$13.5M	0.4%	94
2018 Q4	$29.8M	Sell	601,720 -205,595	-25%	-$12.6M	0.3%	105
2018 Q3	$69.7M	Sell	807,315 -10,865	-1%	-$774K	0.62%	74
2018 Q2	$47.5M	Sell	818,180 -90,930	-10%	-$4.44M	0.46%	90
2018 Q1	$36.6M	Buy	909,110 +68,655	+8%	+$2.59M	0.4%	99
2017 Q4	$29.3M	Buy	+840,455	New	+$27.9M	0.33%	96

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Champlain Investment Partners's TDOC Position: Q2 2020 in Review

Champlain Investment Partners sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 212,305 shares — an estimated $32.9M sold.

Champlain Investment Partners first reported a position in TDOC in Q4 2017 and held it in 10 quarters. The position peaked at $106M in Q4 2019. 669 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Champlain Investment Partners reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Champlain Investment Partners sold 212,305 Teladoc Health shares in Q2 2020, an estimated $32.9M.
Champlain Investment Partners first reported a position in Teladoc Health in Q4 2017 and held it in 10 quarters.
Champlain Investment Partners's Teladoc Health position peaked at $106M in Q4 2019.
669 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Champlain Investment Partners's 13F filing for Q2 2020, filed 13 Aug 2020.